Breaking News

B'luru hosp gets nod for plasma therapy trials


The Drug Controller General of India (DCGI) has authorised Bengaluru’s HCG Bangalore Institute of Oncology Speciality Centre to go ahead with medical trials in convalescent plasma therapy for significantly ill Covid-19 patients. The Bengaluru centre received the letter via DCGI Dr VG Somani on Monday, after a three-week wait.


No comments